What is Bloomer Tech?
Bloomer Tech operates at the intersection of femtech and medical diagnostics, specializing in the development of digital biomarkers tailored specifically to female physiology. By focusing on precision cardiovascular care, the company provides clinicians with actionable, real-time data that is critical for the early detection and management of heart disease in women. This technological infrastructure addresses a long-standing disparity in clinical research, where female-specific physiological data has historically been underrepresented. Through its innovative approach, Bloomer Tech is establishing a new standard for personalized healthcare, transforming how heart conditions are identified and treated on a global scale.
How much funding has Bloomer Tech raised?
Bloomer Tech has raised a total of $3M across 1 funding round:
Angel/Seed
$3M
Angel/Seed (2020): $3M with participation from One Brave Idea and Material Impact
Key Investors in Bloomer Tech
Material Impact
Material Impact is a venture capital firm dedicated to building deep tech companies that leverage material science to drive innovation and solve complex global challenges.
One Brave Idea
One Brave Idea is a research-focused initiative dedicated to uncovering the root causes of coronary heart disease and developing transformative solutions for cardiovascular health.
What's next for Bloomer Tech?
With this major strategic investment, Bloomer Tech is poised to accelerate its research and development initiatives, focusing on the expansion of its clinical data sets and the refinement of its diagnostic algorithms. The company's roadmap includes deepening its integration with existing healthcare systems to ensure that its digital biomarkers become a standard component of routine cardiovascular screenings. By leveraging this capital, Bloomer Tech aims to solidify its market position as a leader in the femtech sector, ultimately driving better patient outcomes and fostering a more inclusive approach to medical innovation. The focus remains on scaling operations to meet the increasing demand for gender-specific health solutions in the enterprise medical market.
See full Bloomer Tech company page
